JP2015508780A5 - - Google Patents

Download PDF

Info

Publication number
JP2015508780A5
JP2015508780A5 JP2014557870A JP2014557870A JP2015508780A5 JP 2015508780 A5 JP2015508780 A5 JP 2015508780A5 JP 2014557870 A JP2014557870 A JP 2014557870A JP 2014557870 A JP2014557870 A JP 2014557870A JP 2015508780 A5 JP2015508780 A5 JP 2015508780A5
Authority
JP
Japan
Prior art keywords
use according
composition
administering
immunocompromised patients
inhaler
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014557870A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015508780A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/026754 external-priority patent/WO2013123521A1/en
Publication of JP2015508780A publication Critical patent/JP2015508780A/ja
Publication of JP2015508780A5 publication Critical patent/JP2015508780A5/ja
Pending legal-status Critical Current

Links

JP2014557870A 2012-02-17 2013-02-19 免疫不全患者のインフルエンザ及びパラインフルエンザウイルスを処置するための方法、化合物、及び組成物 Pending JP2015508780A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261600545P 2012-02-17 2012-02-17
US61/600,545 2012-02-17
US201261727627P 2012-11-16 2012-11-16
US61/727,627 2012-11-16
PCT/US2013/026754 WO2013123521A1 (en) 2012-02-17 2013-02-19 Methods, Compounds and Compositions for Treatment of Parainfluenza Virus in Immunocompromised Patients

Publications (2)

Publication Number Publication Date
JP2015508780A JP2015508780A (ja) 2015-03-23
JP2015508780A5 true JP2015508780A5 (enExample) 2016-04-21

Family

ID=48984833

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014557870A Pending JP2015508780A (ja) 2012-02-17 2013-02-19 免疫不全患者のインフルエンザ及びパラインフルエンザウイルスを処置するための方法、化合物、及び組成物

Country Status (9)

Country Link
US (5) US20130280332A1 (enExample)
EP (1) EP2841092B1 (enExample)
JP (1) JP2015508780A (enExample)
CN (2) CN104203267A (enExample)
AU (3) AU2013221230A1 (enExample)
CA (1) CA2864746A1 (enExample)
ES (1) ES2970401T3 (enExample)
IL (2) IL234116B (enExample)
WO (1) WO2013123521A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX354217B (es) 2010-05-14 2018-02-19 Dana Farber Cancer Inst Inc Composiciones y metodos para el tratamiento de leucemia.
EP2571875A4 (en) 2010-05-14 2013-10-30 Dana Farber Cancer Inst Inc CONTRACEPTIVE COMPOSITIONS FOR MEN AND METHODS OF USE THEREOF
PL2902030T3 (pl) 2010-05-14 2017-07-31 Dana-Farber Cancer Institute, Inc. Związki tienotriazolodiazepinowe do leczenia nowotworu
US9975896B2 (en) 2013-07-25 2018-05-22 Dana-Farber Cancer Institute, Inc. Inhibitors of transcription factors and uses thereof
RU2016122654A (ru) 2013-11-08 2017-12-14 Дана-Фарбер Кэнсер Инститьют, Инк. Комбинированная терапия злокачественной опухоли с использованием ингибиторов бромодоменового и экстратерминального (вет) белка
EP3099677A4 (en) 2014-01-31 2017-07-26 Dana-Farber Cancer Institute, Inc. Diaminopyrimidine benzenesulfone derivatives and uses thereof
US10793571B2 (en) 2014-01-31 2020-10-06 Dana-Farber Cancer Institute, Inc. Uses of diazepane derivatives
JP2017506666A (ja) 2014-02-28 2017-03-09 テンシャ セラピューティクス,インコーポレイテッド 高インスリン血症に関連した症状の処置
CN106715437A (zh) 2014-08-08 2017-05-24 达纳-法伯癌症研究所股份有限公司 二氮杂环庚烷衍生物及其用途
CN106793775B (zh) 2014-08-08 2020-06-02 达纳-法伯癌症研究所股份有限公司 二氢碟啶酮衍生物及其用途
KR20170068597A (ko) 2014-10-27 2017-06-19 텐샤 세러퓨틱스 인코포레이티드 브로모도메인 저해제
US20190000860A1 (en) * 2014-11-06 2019-01-03 Dana-Farber Cancer Institute, Inc. Use of compositions modulating chromatin structure for graft versus host disease (gvhd)
WO2016073956A1 (en) 2014-11-06 2016-05-12 Dana-Farber Cancer Institute, Inc. Ezh2 inhibitors and uses thereof
WO2016200916A1 (en) * 2015-06-08 2016-12-15 Ansun Biopharma, Inc. Treatment of human metapneumovirus
WO2016201370A1 (en) 2015-06-12 2016-12-15 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
RU2018112953A (ru) 2015-09-11 2019-10-14 Дана-Фарбер Кэнсер Инститьют, Инк. Ацетамидтиенотриазолодиазепины и пути их применения
EP3347021A4 (en) 2015-09-11 2019-07-24 Dana-Farber Cancer Institute, Inc. CYANOTHIENOTRIAZOLDIAZEPINE AND USES THEREOF
MX2018006499A (es) 2015-11-25 2018-08-01 Dana Farber Cancer Inst Inc Inhibidores de bromodominio bivalentes y usos de los mismos.
JP7493304B2 (ja) 2016-04-22 2024-05-31 ダナ-ファーバー キャンサー インスティテュート, インコーポレイテッド Ezh2インヒビターおよびそれらの使用
US20230330140A1 (en) * 2019-11-25 2023-10-19 Ansun Biopharma, Inc. Immune cell delivery of sialidase cancer cells, immune cells and the tumor microenvironment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8245708B2 (en) * 2002-05-07 2012-08-21 The Research Foundation Of State University Of New York Methods, devices and formulations for targeted endobronchial therapy
WO2004022128A2 (en) * 2002-09-06 2004-03-18 Chrysalis Technologies Incorporated Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols
US7807174B2 (en) * 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
CA2506526C (en) 2002-11-22 2017-04-18 Mang Yu Broad spectrum anti-viral therapeutics and prophylaxis
CN101404980A (zh) * 2006-01-24 2009-04-08 耐百生物制药有限公司 大分子微球的制备技术
AU2010315024B2 (en) 2009-11-06 2015-02-12 Nexbio, Inc. Methods, compounds and compositions for treatment and prophylaxis in the respiratory tract

Similar Documents

Publication Publication Date Title
JP2015508780A5 (enExample)
IL273194B2 (en) Methods, compounds and preparations for the treatment of parainfluenza virus in patients with a deficiency in the immune system
BR112013028572B8 (pt) Bocais para distribuição de droga nasal
PH12014502662A1 (en) Novel dosage form and formulation of abediterol
IL216468B (en) Pharmaceutical compositions deliverable from a metered dose inhaler comprising glycopyrrolate and formoterol and their use in treatment of pulmonary diseases
PH12014500551A1 (en) Pharmaceutical composition for inhalation
MX377175B (es) Solucion para inhalacion de tiotropio, administrada en forma nebulizada y el uso de la misma para tratar enfermedad pulmonar obstructiva crónica (epoc).
MD4369B1 (ro) Utilizarea glicopirolatului pentru tratarea tahicardiei, doză unică, dispozitiv de administrare, metodă de tratament şi profilaxie a tahicardiei
JP2014528470A5 (enExample)
MX2021006585A (es) Ciclosporina a en forma solubilizada en liposomas (l-csa) para usarse en el tratamiento de enfermedades pulmonares mediante la inhalación de un aerosol generado por un nebulizador.
WO2012047182A3 (en) Single dose dry powder inhalation device
JP2014530231A5 (enExample)
EA202091199A1 (ru) Лекарственное средство для предотвращения или лечения риновирусной инфекции
MX2018013475A (es) Acido carboxilico para tratar/prevenir congestion nasal.
CN204092782U (zh) 一种医用雾化器
MX2020010977A (es) Procedimientos de tratamiento de infecciones fúngicas.
JP2013522295A5 (enExample)
JP2024546179A5 (enExample)
CN204233551U (zh) 辅助呼吸气雾气体的装置
BR112013020632A8 (pt) Composição farmacêutica para a administração tópica
EA201201394A1 (ru) Ингалятор для доставки лекарственного средства в виде сухого порошка
PH12020552075A1 (en) Hepatitis b vaccine transnasal administration system
EP4005565A1 (en) Novel uses of adamantane derivatives
CN202777337U (zh) 一种带有面部挡板的医用雾化器
CN204601325U (zh) 一种药液雾化吸雾面罩